Find the answers and resources you need about sacral neuromodulation therapy from Medtronic.

 

Clinic Finder – Find a center near you

This map presents a list of centers offering treatments and advanced therapies for Bladder and/or Bowel Control:

  • Blue: Treatment of Faecal disorders
  • Yellow: Treatment of Urinary incontinence
  • Green: Treatment of urinary disorders and faecal incontinence
  • Red: Private Clinics

Click on each icon to obtain contact details of health establishments and urology and/or digestive surgery services.

Consult your doctor for more information.


 

FAQ about bladder and bowel control therapy

Delivered by the InterStim™ sacral neuromodulation system

Expand All

Why does the InterStim™ therapy target the sacral nerves ?

Is the evaluation phase reversible?

What are the risks of the InterStim™ system ?

How long does the device last ?

Why is this therapy different from other advanced options ?

Will I be able to get an MRI with the implantable device ?

How long has the InterStim™ system been available ?

Will the Interstim™ system limit my activities?


Resources

Useful Links



† Under expected therapy settings and telemetry use
‡ Anticholinergic/antimuscarinic medication.
§ Under certain conditions; see approved labeling for details. Patients with InterStim™ SureScan™ MRI leads only.

Information contained herein is not medical advice and should not be used as an alternative to speaking with your doctor. Discuss indications, contraindications, warnings, precautions, adverse events and any further information with your health care professional.

References

1

Patton V, Wiklendt L, Arkwright JW, et al. The effect of sacral nerve stimulation on distal colonic motility in patients with fecal incontinence. Br J Surg. 2013;100(7):959–968.

2

Leng WW, Morrisroe SN. Sacral nerve stimulation for the overactive bladder. Urol Clin N Am. 2006;33:491–501. 

3

Chancellor MB, Chartier-Kastler EJ. Principles of sacral nerve stimulation (SNS) for the treatment of bladder and urethral sphincter dysfunctions. Neuromod. 2000;3(1):15–26.

4

Siegel S, Noblett K, Mangel J, et al. Results of a prospective, randomized, multicenter study evaluating sacral neuromodulation with InterStim™ therapy compared to standard medical therapy at six months in subjects with mild symptoms of overactive bladder. Neurourol Urodyn. 2015;34:224–230. 

5

Chohan N, Hilton P, Brown K, Dixon L. Efficacy and duration of response to botulinum neurotoxin A (onabotulinumA) as a treatment for detrusor overactivity in women. Int Urogynecol J Pelvic Floor Dysfunct. 2015;26(11):1605-1612.

6

InterStim Implant Numbers, version 2.0, July-2023